EMBRACE, eribulin, and new realities of advanced breast cancer.
Saved in:
| Title: | EMBRACE, eribulin, and new realities of advanced breast cancer. |
|---|---|
| Authors: | Lin, Nancy U. (AUTHOR), Burstein, Harold J. (AUTHOR) |
| Source: | Lancet. 3/12/2011, Vol. 377 Issue 9769, p878-880. 3p. |
| Subjects: | Breast cancer research, Breast cancer patients, Breast cancer treatment, Quality of life, Drug therapy |
| Abstract: | In this article the authors discuss the Epidemiological Study of Familial Breast Cancer (EMBRACE) study and facts regarding advanced breast cancer. The authors say that EMBRACE study is a phase three study which compares eribulin or treatment of physician's choice (TPC) for advanced breast cancer. They argue that the EMBRACE study shows that chemotherapy of breast cancer is improving and enhances the quality of life of cancer patients. |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 60726984 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: EMBRACE, eribulin, and new realities of advanced breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lin%2C+Nancy+U%2E%22">Lin, Nancy U.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burstein%2C+Harold+J%2E%22">Burstein, Harold J.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lancet%22">Lancet</searchLink>. 3/12/2011, Vol. 377 Issue 9769, p878-880. 3p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Breast+cancer+research%22">Breast cancer research</searchLink><br /><searchLink fieldCode="DE" term="%22Breast+cancer+patients%22">Breast cancer patients</searchLink><br /><searchLink fieldCode="DE" term="%22Breast+cancer+treatment%22">Breast cancer treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+of+life%22">Quality of life</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+therapy%22">Drug therapy</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: In this article the authors discuss the Epidemiological Study of Familial Breast Cancer (EMBRACE) study and facts regarding advanced breast cancer. The authors say that EMBRACE study is a phase three study which compares eribulin or treatment of physician's choice (TPC) for advanced breast cancer. They argue that the EMBRACE study shows that chemotherapy of breast cancer is improving and enhances the quality of life of cancer patients. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=60726984 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(11)60280-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 3 StartPage: 878 Subjects: – SubjectFull: Breast cancer research Type: general – SubjectFull: Breast cancer patients Type: general – SubjectFull: Breast cancer treatment Type: general – SubjectFull: Quality of life Type: general – SubjectFull: Drug therapy Type: general Titles: – TitleFull: EMBRACE, eribulin, and new realities of advanced breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin, Nancy U. – PersonEntity: Name: NameFull: Burstein, Harold J. IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 03 Text: 3/12/2011 Type: published Y: 2011 Identifiers: – Type: issn-print Value: 01406736 Numbering: – Type: volume Value: 377 – Type: issue Value: 9769 Titles: – TitleFull: Lancet Type: main |
| ResultId | 1 |